• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Issues that matter
    • COVID-19 in India
    • Inadequate safe drinking water
    • Poor sanitation
    • Environmental health
    • Infectious disease
      • Hepatitis C
    • Noncommunicable Diseases (NCDs)
    • Malnutrition
    • High infant mortality
    • Mental health
    • Sex and gender discrimination
  • Special Focus
    • Interviews
      • Exclusive Interviews
      • Readers Interviews
    • Vaccine Hesitancy
  • News
  • PandemiCast
  • Partner’s Press Office

Health Issues India

Health issues in India

  • Home
  • About Us
  • Editorial Team
  • Subscribe
  • Contribute
  • Sponsor
  • Contact Us
You are here: Home / Featured / Japan – the new opportunity Indian pharma needs?

Japan – the new opportunity Indian pharma needs?

October 28, 2016 By Kerean Watts Leave a Comment

Share

Could Japan be a new, opportune market for Indian pharma?

Recent comments by Indian Commerce and Industry Minister Nirmala Sitharaman seem to suggest as much.

At a seminar in New Delhi, organised by the Research and Information System for Developing Countries (RIS) think tank, Sitharaman encouraged Indian companies to increase exports to Japan under the Comprehensive Economic Partnership Agreement (CEPA) between the two countries.

Noting that the India-Japan trade deficit had increased from $3.1 billion in 2011 when the agreement was linked to $5.2 billion afterwards, Sitharaman singled out the pharmaceutical industry in India, calling its present share in the US$110 billion Japanese pharma market “below par” – it being limited to active pharmaceutical ingredients (API) –  whilst the market itself offers “a huge untapped potential for Indian pharma industry.”

Sitharaman stated that India’s “strength in pharma sector was well-established” and that the country’s role as a pre-eminent exporter of generic drugs – predominantly to less economically developed countries (LEDCs) – was compatible with the objectives of the Japanese government to lower the costs of healthcare in order to better accommodate the demands of the country’s ageing population.

As prognosticators of sorts,India-based pharmaceutical companies such as Lupin have enjoyed considerable success in Japan  

Lupin is one of the fastest growing generic drug companies in Japan, with its subsidiary Kyowa ranking ninth – and is now expected to rank sixth following a US$150 million acquisition earlier this year of twenty-one generic drug brands from the Osaka-based pharma company Shionogi & Co.  

The Japanese government announced last year its intentions to raise the share of generic drug prescriptions to 80% by 2020.

Filed Under: Featured

About Kerean Watts

Kerean Watts has been a featured writer for Health Issues since 2016. His areas of study include politics, international relations and global development. He is based in South Wales.

Reader Interactions

Leave a Reply Cancel reply

You must be logged in to post a comment.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Primary Sidebar

Articles

  • US declares monkeypox a public health emergency; The latest health stories from around the world
  • First Asian monkeypox death occurs in India
  • President Joe Biden tests positive for COVID-19 a second time; The latest health stories from around the world
  • Monkeypox officially declared a global emergency by WHO; The latest health stories from around the world
  • Four monkeypox cases now reported in India

Footer

Archives

Issues that matter

  • Environmental health
  • Inadequate safe drinking water
  • Poor sanitation
  • Infectious disease
  • Noncommunicable Diseases (NCDs)
  • Malnutrition
  • High infant mortality

Categories

Copyright © 2022 · News Pro On Genesis Framework · WordPress · Log in

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies. However you may visit Cookie Settings to provide a controlled consent.
Cookie settingsACCEPTACCEPT ALL
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.